{
    "clinical_study": {
        "@rank": "41994", 
        "arm_group": [
            {
                "arm_group_label": "Adenosine Vasodilation test", 
                "description": "Group scanned with CT perfusion during adenosine vasodilation test."
            }, 
            {
                "arm_group_label": "Reference group", 
                "description": "Group scanned twice without adenosine vasodilation test for a reference. No randomization."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study was to investigate changes in abdominal tissue perfusion during\n      adenosine vasodilation. Our hypotheses were that CT perfusion measurements are altered by\n      changes in the circulatory system mediated by adenosine, and a more differentiated\n      assessment of the circulatory capacity of abdominal tumours could be achieved by sequential\n      rest and adenosine vasodilation CT perfusion measurements."
        }, 
        "brief_title": "CT Perfusion Changes in GI Cancer During Adenosine Vasodilation Test", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Esophageal Cancer", 
            "Gastric Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Esophageal Neoplasms", 
                "Stomach Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Tumour larger than 1.5 cm on diagnostic CT\n\n          -  Normal serum creatinine\n\n          -  Age above 18\n\n          -  Informed written and oral consent.\n\n        Exclusion Criteria:\n\n          -  Contrast allergy or contrast induced nephropathy\n\n          -  BMI > 40\n\n          -  Asthma or Chronic Obstructive Lung Disease\n\n          -  Heart failure (NYHA III+)\n\n          -  Heart conduction disorder\n\n          -  Atrial fibrillation\n\n          -  2nd/3rd Heart block\n\n          -  Long QT syndrome\n\n          -  Wolf Parkinson White Syndrome\n\n          -  Moderate / severe aortic stenosis\n\n          -  Haemodynamic contraindications for adenosine, systolic pressure below 90"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with biopsy proven tumors in esophagus or stomach"
            }
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02074124", 
            "org_study_id": "H-3-2012-067", 
            "secondary_id": "H-3-2012-067"
        }, 
        "intervention_browse": {
            "mesh_term": "Adenosine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 26, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "zip": "2100"
                }, 
                "name": "Rigshospitalet"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_groups": "2", 
        "official_title": "Abdominal Tissue Perfusion Changes in Esophageal and Gastric Cancer During Adenosine Vasodilation Measured With Computed Tomography (CT) Perfusion", 
        "overall_official": {
            "affiliation": "Rigshospitalet, Denmark", 
            "last_name": "Martin L Hansen, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Denmark: The Regional Committee on Biomedical Research Ethics", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change in arterial flow during adenosine vasodilation test (CT perfusion parameter)", 
            "safety_issue": "No", 
            "time_frame": "0 min and 15 min"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02074124"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "Martin Lundsgaard Hansen", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in Blood pressure during adenosine vasodilation test", 
                "safety_issue": "No", 
                "time_frame": "0 min and 15 min"
            }, 
            {
                "measure": "Change in Heart rate during adenosine vasodilation test", 
                "safety_issue": "No", 
                "time_frame": "0 min and 15 min"
            }, 
            {
                "description": "Area Under Curve (AUC) is correlated to cardiac output", 
                "measure": "Change in Area under arterial input curve during adenosine vasodilation test", 
                "safety_issue": "No", 
                "time_frame": "0 min and 15 min"
            }, 
            {
                "measure": "Change in Blood volume (CT perfusion parameter) during adenosine vasodilation test", 
                "safety_issue": "No", 
                "time_frame": "0 min and 15 min"
            }, 
            {
                "measure": "Change in Permeability (CT perfusion parameter) during adenosine vasodilation test.", 
                "safety_issue": "No", 
                "time_frame": "0 min and 15 min"
            }
        ], 
        "source": "University of Copenhagen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Copenhagen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}